276 related articles for article (PubMed ID: 20874497)
21. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.
Jin Y; Arita M; Zhang Q; Saban DR; Chauhan SK; Chiang N; Serhan CN; Dana R
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4743-52. PubMed ID: 19407006
[TBL] [Abstract][Full Text] [Related]
22. Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model.
Kim CE; Kim YJ; Hwang MW; Park YJ; Yang J
Biomed Pharmacother; 2021 Jul; 139():111571. PubMed ID: 33857915
[TBL] [Abstract][Full Text] [Related]
23. Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities.
Ji YW; Seo Y; Choi W; Yeo A; Noh H; Kim EK; Lee HK
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6829-38. PubMed ID: 25257053
[TBL] [Abstract][Full Text] [Related]
24. Proresolving Mediators LXB4 and RvE1 Regulate Inflammation in Stromal Cells from Patients with Shoulder Tendon Tears.
Dakin SG; Colas RA; Wheway K; Watkins B; Appleton L; Rees J; Gwilym S; Little C; Dalli J; Carr AJ
Am J Pathol; 2019 Nov; 189(11):2258-2268. PubMed ID: 31437425
[TBL] [Abstract][Full Text] [Related]
25. Exposure to a dry environment induces strain-specific responses in mice.
Barabino S; Rolando M; Chen L; Dana MR
Exp Eye Res; 2007 May; 84(5):973-7. PubMed ID: 17397831
[TBL] [Abstract][Full Text] [Related]
26. Resolvin E1 accelerates pulp repair by regulating inflammation and stimulating dentin regeneration in dental pulp stem cells.
Chen J; Xu H; Xia K; Cheng S; Zhang Q
Stem Cell Res Ther; 2021 Jan; 12(1):75. PubMed ID: 33482900
[TBL] [Abstract][Full Text] [Related]
27. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis.
Arita M; Yoshida M; Hong S; Tjonahen E; Glickman JN; Petasis NA; Blumberg RS; Serhan CN
Proc Natl Acad Sci U S A; 2005 May; 102(21):7671-6. PubMed ID: 15890784
[TBL] [Abstract][Full Text] [Related]
28. Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration.
Liu G; Gong Y; Zhang R; Piao L; Li X; Liu Q; Yan S; Shen Y; Guo S; Zhu M; Yin H; Funk CD; Zhang J; Yu Y
FASEB J; 2018 Oct; 32(10):5413-5425. PubMed ID: 29723062
[TBL] [Abstract][Full Text] [Related]
29. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
[TBL] [Abstract][Full Text] [Related]
30. Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin.
Salic K; Morrison MC; Verschuren L; Wielinga PY; Wu L; Kleemann R; Gjorstrup P; Kooistra T
Atherosclerosis; 2016 Jul; 250():158-65. PubMed ID: 27236706
[TBL] [Abstract][Full Text] [Related]
31. The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice.
Aoki S; Deyama S; Sugie R; Ishimura K; Fukuda H; Shuto S; Minami M; Kaneda K
Behav Brain Res; 2022 Feb; 418():113676. PubMed ID: 34801580
[TBL] [Abstract][Full Text] [Related]
32. sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.
Wei Y; Epstein SP; Fukuoka S; Birmingham NP; Li XM; Asbell PA
Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4780-8. PubMed ID: 21519031
[TBL] [Abstract][Full Text] [Related]
33. Resolvin E1 attenuates murine psoriatic dermatitis.
Sawada Y; Honda T; Nakamizo S; Otsuka A; Ogawa N; Kobayashi Y; Nakamura M; Kabashima K
Sci Rep; 2018 Aug; 8(1):11873. PubMed ID: 30089836
[TBL] [Abstract][Full Text] [Related]
34. Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice.
Liu G; Liu Q; Shen Y; Kong D; Gong Y; Tao B; Chen G; Guo S; Li J; Zuo S; Yu Y; Yin H; Zhang L; Zhou B; Funk CD; Zhang J; Yu Y
Br J Pharmacol; 2018 Apr; 175(8):1205-1216. PubMed ID: 28925017
[TBL] [Abstract][Full Text] [Related]
35. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Kim TH; Kim GD; Jin YH; Park YS; Park CS
Int Immunopharmacol; 2012 Dec; 14(4):384-91. PubMed ID: 22951188
[TBL] [Abstract][Full Text] [Related]
36. Resolvin E1 protects the rat heart against reperfusion injury.
Keyes KT; Ye Y; Lin Y; Zhang C; Perez-Polo JR; Gjorstrup P; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H153-64. PubMed ID: 20435846
[TBL] [Abstract][Full Text] [Related]
37. A unique radioprotective effect of resolvin E1 reduces irradiation-induced damage to the inner ear by inhibiting the inflammatory response.
Zhang J; Xu A; Niu T; Liu C; Zhang Y; Li T; Wang J; Wang Y; Sun D
Radiat Oncol; 2020 Sep; 15(1):223. PubMed ID: 32977807
[TBL] [Abstract][Full Text] [Related]
38. Resolvin E1 Reduces Tumor Growth in a Xenograft Model of Lung Cancer.
Kantarci A; Kansal S; Hasturk H; Stephens D; Van Dyke TE
Am J Pathol; 2022 Oct; 192(10):1470-1484. PubMed ID: 35944728
[TBL] [Abstract][Full Text] [Related]
39. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.
Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC
Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509
[TBL] [Abstract][Full Text] [Related]
40. Resolvin E1 as a novel agent for the treatment of asthma.
Hisada T; Ishizuka T; Aoki H; Mori M
Expert Opin Ther Targets; 2009 May; 13(5):513-22. PubMed ID: 19368495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
